Marie Newman sold Moderna Inc (NASDAQ: MRNA)
Marie Newman (D-IL), a U.S. Representative, has disclosed 10 trades in Moderna Inc (MRNA) since 2021, 3 purchases and 7 sales, worth an estimated $154K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Marie Newman sold $15,001 - $50,000 of Moderna Inc (NASDAQ: MRNA) on January 8, 2021. Since that trade, MRNA is down -51.67% against the S&P 500 up +105.53%, an outperformance of -157.20%.
Across these filings, Marie Newman has been a net seller of MRNA (a buy-to-sell ratio of 0.43). The most recent disclosed MRNA transaction shown was dated January 29, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Marie Newman's MRNA trades vs the price
MRNA is down -51.67% since Marie Newman sold on January 8, 2021, versus +105.53% for the S&P 500.
Performance since this trade
All Marie Newman MRNA trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Marie Newman & MRNA trading FAQ
Is it legal for Marie Newman to trade Moderna Inc (MRNA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Moderna Inc (MRNA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Marie Newman sell MRNA?
Marie Newman disclosed a sale of $15,001 - $50,000 of Moderna Inc (MRNA) on January 8, 2021, according to public STOCK Act filings.
How has MRNA performed since Marie Newman's trade?
Since Marie Newman sold MRNA on January 8, 2021, the stock is down -51.67%, versus +105.53% for the S&P 500 over the same period, an outperformance of -157.20%.
How many times has Marie Newman traded MRNA?
Marie Newman has disclosed 10 MRNA trades since 2021 (3 purchases and 7 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MRNA trades?
Quantellect tracks every disclosed congressional trade in Moderna Inc (MRNA) on the Moderna Inc congressional trading page, which aggregates filings across all members of Congress.
Marie Newman's MRNA tradesAll congressional filings for Moderna IncMarie Newman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.